Perianal Abscess Clinical Trial
— PPACOfficial title:
Packing of Perianal Abscess Cavities (PPAC) Trial: A Randomised Multicentre Trial Comparing Packing With Non-packing of the Abscess Cavity
The aim of this study is to compare the effect of packing and non-packing on the healing rate of perianal abscess cavities. Secondary objectives are to assess quality of life, cost effectiveness and rate of abscess recurrence and fistula-in-ano formation. If there is no difference in time to healing and non-packing is shown to be safe, acceptable to the patient and cost effective, this approach may become more widely accepted.
Status | Not yet recruiting |
Enrollment | 300 |
Est. completion date | December 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of acute primary perianal abscess - Have undergone surgical incision and drainage as an emergency Exclusion Criteria: - The abscess is the sequelae of concurrent disease or trauma - Fourniers gangrene is suspected - Unable to give informed consent |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
North Western Research Collaborative |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Abscess recurrence rate | 0 days to 12 months | Yes | |
Other | Fistula-in-ano formation rate | 0 days to 18 months | Yes | |
Other | Cost | 0 days to 18 months | No | |
Primary | Time to wound healing in days, defined as complete epithelialisation of the abscess cavity. | time to healing will be assessed in days | 1 day to 6 weeks | No |
Secondary | Quality of life scores as determined by the Euro QoL EQ-5D-3L | Quality of life scores as determined by the Euro QoL EQ-5D-3L will be measured at 10-14 days following incision and drainage of abscess | 10 to 14 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04549311 -
Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial
|
Phase 3 | |
Completed |
NCT01853267 -
Perianal Abscess Packing Randomized ControlledTrial Pilot Study
|
N/A | |
Not yet recruiting |
NCT05862129 -
Association of Intestinal Microbiota and the Onset of Perianal Abscess Based on 16S rDNA Amplicon Sequencing
|
||
Completed |
NCT05193032 -
Abces After Incision: Recurrence or Not?
|
||
Completed |
NCT04832529 -
A Perianal Abscess Cavity Packing vs no Packing.
|
N/A | |
Completed |
NCT05529628 -
The Immunological Differences Between Fournier Gangrene and Perianal Abscess
|
||
Completed |
NCT02410707 -
Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults
|
N/A | |
Completed |
NCT03315169 -
Packing of Perianal Abscess Cavities
|
N/A | |
Recruiting |
NCT05385887 -
Antibiotic Treatment foLlowing Surgical drAinage of Perianal abScess; the ATLAS Trial
|
N/A | |
Recruiting |
NCT02306382 -
Multicenter Study for Diagnosis and Treatment of Perianal Abscesses
|
N/A | |
Completed |
NCT00972088 -
Prevalence of Inflammatory Bowel Disease in Patients With Perianal Disease
|
N/A | |
Recruiting |
NCT05990569 -
Pudendal Nerve Block With Bupivacaine Alone and Bupivacaine With Methylene Blue for Postoperative Analgesia
|
N/A | |
Recruiting |
NCT06446635 -
Semiflex Assisted Vacuum Therapy for Perianal Abscesses/Sinuses and Fistula: a Pilot Study
|
N/A |